Insider Trading & Ownership - Hansard Adam

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Hansard Adam
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-03-14
Sale
2024-03-18
6:00 pm
Applied Therapeutics Inc. APLT Hansard Adam
Chief Commercial Officer
48,871 $5.39 $263,415 732,919
(Direct)
View
2023-11-30
Sale
2023-12-01
7:42 pm
Applied Therapeutics Inc. APLT Hansard Adam
Chief Commercial Officer
965 $1.97 $1,901 381,790
(Direct)
View
2023-09-27
Sale
2023-09-29
8:02 pm
Applied Therapeutics Inc. APLT Hansard Adam
Chief Commercial Officer
9,720 $2.7 $26,244 382,755
(Direct)
View
2023-01-11
Sale
2023-01-13
4:30 pm
Applied Therapeutics Inc. APLT Hansard Adam
Chief Commercial Officer
4,495 $0.91 $4,090 392,475
(Direct)
View
2021-05-26
Sale
2021-05-28
7:12 pm
Applied Therapeutics Inc. APLT Hansard Adam
Chief Commercial Officer
2,894 $18.35 $53,105 33,570
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-12-21
Option Award
2023-12-22
8:01 pm
N/A
N/A
Applied Therapeutics Inc. APLT Hansard Adam
Chief Commercial Officer
400,000 $0 781,790
(Direct)
View
2023-01-11
Option Award
2023-01-13
4:30 pm
N/A
N/A
Applied Therapeutics Inc. APLT Hansard Adam
Chief Commercial Officer
300,000 $0 392,475
(Direct)
View
2022-04-13
Option Award
2022-04-15
7:07 pm
N/A
2032-04-13
Applied Therapeutics Inc. APLT Hansard Adam
Chief Commercial Officer
50,000 $0 50,000
(Direct)
View
2022-01-07
Option Award
2022-01-11
6:44 pm
N/A
2032-01-07
Applied Therapeutics Inc. APLT Hansard Adam
Chief Commercial Officer
52,800 $0 118,070
(Direct)
View
2021-12-14
Option Award(A)
2022-01-11
6:41 pm
N/A
N/A
Applied Therapeutics Inc. APLT Hansard Adam
Chief Commercial Officer
31,700 $0 65,270
(Direct)
View
2021-12-14
Option Award
2021-12-16
8:29 pm
N/A
2031-12-14
Applied Therapeutics Inc. APLT Hansard Adam
Chief Commercial Officer
52,800 $0 86,370
(Direct)
View
2020-12-10
Option Award
2020-12-14
9:42 pm
N/A
2030-12-10
Applied Therapeutics Inc. APLT Hansard Adam
Chief Commercial Officer
81,700 $0 81,700
(Direct)
View
(A) Indicate amendment filing.